Terra Innovatum Global N.V. reported a widened first-quarter 2026 loss, remaining pre-revenue as it advances development and regulatory engagement for its SOLO micro‑modular reactor. The company recorded a net loss of $(7.106M) and diluted loss per share of $(0.06) for Q1 2026 versus a $(1.448M) loss and $(0.03) diluted loss per share in Q1 2025; the company has not reported product revenue for the period.

Financial Highlights

  • Net income: $(7.106M) for Q1 2026, versus $(1.448M) in Q1 2025 (loss widened by $5.658M YoY).
  • Diluted earnings per share: $(0.06) for Q1 2026, versus $(0.03) in Q1 2025 (loss per share doubled YoY).
  • Revenue: Not reported for Q1 2026 (company remains pre‑revenue; no product sales).

Business Highlights

  • Product development: SOLO micro‑modular reactor design is complete for component fabrication, with the company targeting a first-of-a-kind (FOAK) licensing and commercial deployment by 2028.
  • Operations and regulatory progress: Initiated regulatory engagement with the Nuclear Regulatory Commission (NRC) and validated key components as part of development milestones.
  • Commercial preparation: Established European assembly preparations and a global supply‑chain strategy to support future deployment.
  • Revenue outlook: No product revenue yet; meaningful commercialization and revenue are not expected before 2028 and remain dependent on regulatory approvals and execution.
  • Risks: The company notes limited cash runway despite recent PIPE/closing proceeds and highlights ongoing R&D, regulatory and supply‑chain execution risks to advancing commercialization.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.